Abstract P5-10-25: Exploring JAM2's Potential in Reducing Breast Cancer Invasiveness through IGF2BP2 Regulation

Peng Yang(Chinese Academy of Sciences), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Ailin Lan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zehao Cai(Capital Medical University), Yang Liu(Mudanjiang Medical University), Li Han(Huadong Hospital)
Clinical Cancer Research
June 13, 2025
10.1158/1557-3265.sabcs24-p5-10-25
Cited by 0

Related Papers

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells
|The Journal of Immunology|2004|182
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
|PLoS Genetics|2016|130
Chronic <scp>mTOR</scp> inhibition in mice with rapamycin alters <scp>T</scp> , <scp>B</scp> , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
|Aging Cell|2015|128